You’ve heard of steroids a lot, right? Usually, adrenocortical hormone drugs are called steroid drugs. The cortical hormone drugs are made of drugs that control protein, fat metabolism, and immune response inflammatory reactions. However, while steroids are very effective, they can cause many side effects, so you have to be careful. 소론도정 부작용
“Soron Dojeong” released by Yuhan Corporation is known as a treatment for a wide range of diseases including endocrine disorders. Synthetic Busan cortical hormone drugs, which have anti-inflammatory or immunosuppressive effects, cannot be purchased separately at pharmacies and can be purchased under the prescription of a doctor. I will look into Soron Dojeong, a steroid drug.
Basic information on the theory of the government
Product name: Soron Dojeong (Frednisolone) jasminevista.comjasminevista.com jasminevista.com
Shape: Round
Name of company: Limited
Consignment manufacturer: Co., Ltd
full text/general: over-the-counter medicine
Permission date: 1996-04-23
Item standard code: 199602982
Standard code: 8806421050202, 8806421050219, 8806475003506, 8806475003513, 8806475003520
Identification mark: YM020009 Long axis size: 7.1 mm Short axis size: 7.1 mm Thickness: 2.7 mm Divided line (back): –
Raw ingredients and quantity: 5 milligrams of prednisolone
Additives: Lactose hydrate, stearic acid, corn starch, magnesium stearate
* Because the drug contains lactose, it should not be administered to patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, and glucose-galactose uptake disorder.*
Packaging information: 1,000 sheets / bottle
Soron Dojeong Efficacy
Yuhan Corporation’s Soron Dojeong is a prednisolone component that helps treat various inflammations. It is a drug that can be treated extensively.
1. Endocrine disorders: primary and secondary adrenal cortical insufficiency, congenital adrenal dysplasia, hypercalcemia associated with cancer, and non-purulent thyroid gland
2. rheumatic disorder
Adjuvant therapy for short-term administration to prevent acute progression or exacerbation: Rheumatoid arthritis (including juvenile rheumatoid arthritis), ankylosing spondylitis
3. a collagen-based disease
The following diseases that are undergoing deterioration or require maintenance therapy: systemic lupus erythematosus, systemic dermatomyositis (multiple myositis), acute rheumatic pericarditis
4. Skin diseases: sacral plexus, blistering herpes zoster, severe polymorphic erythema (Stevens-Johnson syndrome), severe psoriasis, severe seborrheic dermatitis, and mycorrhizal sarcoma
5. an allergic disease
The following diseases that are severely allergic and do not respond with general treatment: bronchial asthma, contact dermatitis, atopic dermatitis, seasonal allergic rhinitis, serum disease, drug hypersensitivity reaction
6. an ophthalmic disease
The following diseases related to severe acute allergic or inflammatory eyes and their appendages: iris-shaped vasculitis, choronitis, scattered uveitis in the posterior part, optic inflammation, allergic conjunctivitis, keratitis
7. a gastrointestinal disease
The following diseases to overcome the critical crisis: ulcerative colitis, localized enteritis
8. Respiratory diseases: Syndromal sarcoidosis, fulminant or disseminated pulmonary tuberculosis (administered in combination with appropriate anti-tuberculosis chemotherapy drugs)
9. Blood diseases: acquired (autoimmune) hemolytic anemia, thrombocytopenic purpura of idiopathic severe immune disease in adults, and red euglyopia
10. a neoplastic disease
Conventional management of the following diseases: Leukemia and lymphoma in adults
11. Edema disease: Increased urination and induction and proteinuria relief in nephrotic syndrome caused by erythematous lupus
12. Neurological disease: acute exacerbation of multiple sclerosis
13. Others: tuberculous meningitis (dose in combination with an appropriate anti-tuberculosis chemotherapy drug when blocking or blocking of the subarachnoid membrane)
To prohibit the administration of Soron Dojeong
Do not administer to the next patient.
1) Infections without valid antimicrobial agents, patients with systemic fungal infections (which may worsen the infection by immunosuppressive action)
2) Patients who have a history of hypersensitivity to this drug or its ingredients
3) herpes simplex, herpes zoster, chickenpox patients
4) a live vaccine-administered patient
5) Since this drug contains lactose, it should not be administered to patients with genetic problems such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.
Careful administration
1) In principle, it should not be administered, but it should be administered carefully to the next patient, especially when necessary.